Ada Health Funding, Investors & Competitors

Ada Health has raised $167M across 3 funding rounds, most recently a $30M Series B in February 2022.

Last Ada Health funding round

$30M

Series B · Feb 2022

Cumulative funding Ada Health raised

$167M

across 3 funding rounds

Key investors in Ada Health

  • Vitruvian Partners
  • Leaps by Bayer
  • Samsung Catalyst Fund
  • Farallon Capital Management
  • Bertelsmann
  • Schroders Capital
  • Mutschler Ventures AG
  • Red River West

Ada Health Overview

About Ada Health

Ada Health is a Berlin-based AI health assessment platform founded in 2011. Its app connects users to symptom checkers powered by medical knowledge graphs, available in over 130 countries and 20 languages. Ada partners with health systems like Oxford University Hospitals and non-profits for population health insights.


Founded

2011

HQ

GermanyBerlin

Website

ada.com

Status

Privately held

Customer focus

B2C

Revenue model

Advertising

Ada Health Funding History

Ada Health has raised a total of $167M across 3 funding rounds, plus 1 secondary share sale.

Ada Health's first fundraising round was a $47M Series A in October 2017. The most recent completed round was a $30M Series B in February 2022.

Ada Health funding rounds

Ada Health funding rounds
DateStageInvestorsRaisedDeal Summary
Feb 2022Series BBertelsmann; Farallon Capital Management; Red River West$30MAda Health, a Berlin-based digital health company, develops an AI-powered health assessment and care navigation platform that assists healthcare providers, patients, and consumers in assessing symptoms and navigating care processes. The company announced the closure of its Series B round at $120 million on February 10, 2022, through a $30 million extension led by investors Farallon Capital, Red River West, and Bertelsmann Investments. This followed an initial $90 million Series B raise in May 2021 led by Leaps by Bayer, with participation from Vitruvian Partners, Inteligo Bank, F4, and Mutschler Ventures. The extension funding aims to accelerate Ada's growth, particularly in the US market where it has shown strong commercial traction despite minimal presence, and to further develop its AI solutions, form new partnerships, and build a personalized health operating system. Bertelsmann Investments highlighted Ada as one of its first digital health investments, praising its best-in-class platform and growth potential. Red River West emphasized Ada's US traction and plans to leverage its network of entrepreneurs. Additionally, Schroders Capital became a major investor via a secondary transaction acquiring over $30 million in shares from public and private vehicles. As of February 2022, Ada had registered 11 million users worldwide and was expanding partnerships with companies like Bayer and Novartis while targeting North American health systems. The funding supports continental expansion amid rising demand for digital health solutions.
Dec 2021SecondarySchroders Capital-Schroder UK Public Private Trust, managed by Schroders Capital, announced on 3 December 2021 that it had acquired €11.8 million of Ada Health shares from existing holders, following the Berlin company's Series B financing led by Leaps by Bayer in May 2021 in which Vitruvian Partners, Samsung Catalyst Fund, Inteligo Bank, F4 and Mutschler Ventures had also taken part. Schroders Capital bought more than $30 million of Ada Health secondary shares in total across its public and private vehicles. The managers argued the investment addressed healthcare's cost, access and quality trade-off by supporting earlier diagnosis and more efficient routing of patients to the right care, and framed it against UN Sustainable Development Goal targets on universal health coverage. Ada Health was founded in 2011 by Claire Novorol, Daniel Nathrath and Martin Hirsch and runs an AI symptom assessment and care navigation platform whose consumer app had drawn more than 11 million users since its 2016 global launch, over a million of them in the UK. The company licenses its technology to health systems, insurers and employers alongside the consumer app. The holding was later written down, contributing negatively to the trust's net asset value in 2025.
May 2021Series BLeaps by Bayer (lead); Inteligo; Samsung Catalyst Fund; Mutschler Ventures AG; F4; Vitruvian Partners$91M-
Oct 2017Series AVitruvian Partners (lead); June Fund; William Tunstall-Pedoe; Cumberland VC$47MAda Health is a Berlin-based digital health company founded in 2011 that develops an AI-powered symptom assessment and healthcare navigation platform combining medical knowledge with artificial intelligence to provide personalized health insights and triage users to appropriate care. The platform has been used for millions of assessments worldwide and partners with healthcare systems, insurers, life sciences companies, and nonprofits to integrate symptom analysis into digital health offerings. On October 31, 2017, Ada Health raised a Series A round of approximately €40 million (about $47 million USD), led by Vitruvian Partners with participation from June Fund, William Tunstall-Pedoe, Cumberland VC, and others including L&R Ventures. This followed earlier funding like a €2.4M grant in 2015 and an angel round in 2011. The round supported expansion of Ada's health analytics technologies and growth ambitions. User and assessment metrics emerged later; by 2021, Ada reported over 11 million users and 23-24 million assessments since 2016 launch. Subsequent funding included a 2021 Series B of $90 million (later extended to $120 million in 2022) led by Leaps by Bayer, with Vitruvian Partners continuing participation alongside Samsung Catalyst Fund and others, focusing on US expansion, enterprise offerings, and AI development amid digital health growth accelerated by COVID-19. Ada positioned itself for global scale targeting 1 billion users with high clinical accuracy. Competitive context places Ada among leaders in AI-driven digital health navigation, partnering with entities like Bayer and Novartis, while investors like Vitruvian back high-growth tech disruptors across sectors.

Who has invested in Ada Health?

13 investors have backed Ada Health across its funding rounds, including Vitruvian Partners, Leaps by Bayer, Samsung Catalyst Fund, Farallon Capital Management, Bertelsmann and Schroders Capital.

Lead investors include Leaps by Bayer and Vitruvian Partners.


Ada Health Investors

Investors in Ada Health by funding rounds participated
InvestorHQRoundsRoleFirst check
Vitruvian PartnersUnited KingdomLondon2LeadOct 2017
BertelsmannGermanyGütersloh1ParticipantFeb 2022
InteligoPolandZamosc1ParticipantMay 2021
June FundGermanyBerlin1ParticipantOct 2017
Samsung Catalyst FundUnited StatesSan Francisco, CA1ParticipantMay 2021
Leaps by BayerGermanyLeverkusen1LeadMay 2021
Mutschler Ventures AGSwitzerlandBaar1ParticipantMay 2021
Schroders CapitalUnited KingdomLondon1ParticipantDec 2021
Farallon Capital ManagementUnited StatesSan Francisco, CA1ParticipantFeb 2022
William Tunstall-PedoeUnited KingdomLondon1ParticipantOct 2017
F4United StatesSan Francisco, CA1ParticipantMay 2021

This data is available for Pro users. Sign up to see all 13 Ada Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Ada Health Competitors

Ada Health competitors include listed companies like Nyxoah and Kooth, and private ones like Ro, Sword Health, Noom and Pristyn Care.

Public and private companies comparable to Ada Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
RoUnited StatesNew York City, NYPrivate$598M-$7B11.7x
Sword HealthUnited StatesNew York City, NYPrivate$240M-$4B16.7x
NoomUnited StatesNew York City, NYPrivate$400M-$3.7B9.3x
Pristyn CareIndiaGurgaonPrivate$64M-$1.4B-
NyxoahBelgiumBelgiumPublicly listed$12M($97M)$162M3.2x
KoothUnited KingdomUnited KingdomPublicly listed$85M$13M$90M0.7x

Ada Health Public Comps

Ada Health is still privately-owned, but its public comps include Max Healthcare Institute, Oscar Health, Hims, Compass Pathways, Alignment Healthcare, Ping An Healthcare, JMDC, GoodRx, Teladoc and Helus Pharma.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Max Healthcare Institute$858M$232M12.6x10.2x46.5x36.8x
Oscar Health$12B($391M)0.5x0.4x(15.9x)12.8x
Hims$2.3B$178M3.1x2.4x40.4x23.9x
Compass Pathways-($293M)--(5.8x)(8.4x)
Alignment Healthcare$3.9B$45M0.4x0.3x31.6x10.0x
Ping An Healthcare$815M$52M0.9x0.9x13.4x16.9x
JMDC$324M$88M5.0x4.6x18.4x17.9x
GoodRx$797M$173M1.8x1.8x8.1x5.5x

This data is available for Pro users. Sign up to see all Ada Health competitors and their valuation data.

Start Free Trial

Common questions about Ada Health

When was Ada Health founded?Ada Health was founded in 2011.
Where is Ada Health headquartered?Ada Health is headquartered in Berlin, Germany.
Is Ada Health publicly listed?No, Ada Health is a private, VC-backed company.
How much funding has Ada Health raised?Ada Health has raised $167M across 3 funding rounds.
What was Ada Health's last funding round?Ada Health's last funding round was a $30M Series B in February 2022.
Who are Ada Health's investors?Ada Health's investors include Vitruvian Partners, Bertelsmann, Inteligo, June Fund, Samsung Catalyst Fund, Leaps by Bayer, Mutschler Ventures AG, Schroders Capital, Farallon Capital Management, William Tunstall-Pedoe and 3 others.
Which companies are comparable to Ada Health?Companies comparable to Ada Health include Ro, Sword Health, Noom, Pristyn Care, Nyxoah and Kooth.

See companies similar to Ada Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial